Financials data is unavailable for this security.
View more
Year on year Supergenics Bhd 's revenues fell -4.47% from 10.72m to 10.24m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 345.80k to 176.86k, a -48.85% decrease.
| Gross margin | 47.85% |
|---|---|
| Net profit margin | -10.51% |
| Operating margin | 3.22% |
| Return on assets | -5.00% |
|---|---|
| Return on equity | -11.69% |
| Return on investment | -8.12% |
More ▼
Cash flow in MYRView more
In 2023, Supergenics Bhd increased its cash reserves by 41,867.19%, or 2.40m. Cash Flow from Financing totalled 5.31m or 51.82% of revenues. In addition the company used 1.62m for operations while cash used for investing totalled 1.29m.
| Cash flow per share | -0.0013 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0891 |
|---|---|
| Tangible book value per share | 0.0773 |
More ▼
Balance sheet in MYRView more
| Current ratio | 1.88 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.6101 |
|---|---|
| Total debt/total capital | 0.3798 |
More ▼
Growth rates in MYR
Year on year, growth in earnings per share excluding extraordinary items dropped -49.46%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
| EPS growth(5 years) | -39.03 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -300.82 |
